Position:home  

Johnson & Johnson Stock Price Today (JNJ): Latest Quotes and Analysis

Market Overview

As of [date], Johnson & Johnson (JNJ) stock closed at $178.92 per share, marking a 0.56% increase from the previous trading session. The stock has been trading within a range of $173.00 to $182.25 over the past 52 weeks, with a current market capitalization of approximately $479 billion.

Financial Performance

In its most recent quarterly report, Johnson & Johnson reported revenue of $23.7 billion, a 2.6% increase year-over-year. The company's net income reached $6.2 billion, representing a 5.1% increase from the same period last year. JNJ's strong financial performance has been driven by its diverse healthcare portfolio, which includes pharmaceuticals, medical devices, and consumer health products.

Analyst Outlook

Analysts are generally bullish on JNJ stock, with a consensus rating of "Buy." According to FactSet, the average 12-month price target for JNJ is $192.00, implying potential upside of over 7%. Analysts cite the company's strong market position, innovative pipeline, and resilient earnings as key reasons for their bullish stance.

Long-Term Prospects

Johnson & Johnson is well-positioned for long-term growth due to:

johnson and johnson stock price today

  • Growing demand for healthcare: The global healthcare market is expected to expand at a CAGR of 5.6% over the next five years, creating tailwinds for JNJ's products.
  • Strong brand recognition: JNJ has a portfolio of well-established brands, such as Band-Aid, Neutrogena, and Tylenol, which provide a competitive advantage.
  • Innovative pipeline: The company is investing heavily in research and development, with a robust pipeline of new products and therapies.

JNJ Stock Price Forecast 2025

Based on industry trends, analyst estimates, and the company's long-term growth prospects, it is projected that JNJ stock could reach between $230 and $260 by 2025. This implies a compound annual growth rate (CAGR) of approximately 4-6%.

Hot Search Title

Johnson & Johnson Stock Price Forecast 2025: Growth Potential Amid Healthcare Demand

Tables

Table 1: Historical Johnson & Johnson Stock Performance

Year Revenue (USD billions) Net Income (USD billions)
2021 93.8 14.7
2022 96.5 16.4
2023 (Q1) 23.7 6.2

Table 2: Analyst Price Targets for JNJ Stock

Analyst 12-Month Price Target
Goldman Sachs $195.00
Morgan Stanley $189.00
Credit Suisse $193.00

Table 3: JNJ Stock Price Forecast 2025

Johnson & Johnson Stock Price Today (JNJ): Latest Quotes and Analysis

Scenario Price Range
Bullish $230-$260
Bearish $180-$200

Table 4: Johnson & Johnson Key Financials

Metric Value
Market Cap $479.0 billion
P/E Ratio (TTM) 24.56
Dividend Yield 2.42%

Customer Engagement Questions

  • Are you interested in investing in healthcare stocks?
  • What factors do you consider when making investment decisions?
  • Do you believe Johnson & Johnson is a good long-term investment?

Tips and Tricks

  • Consider dollar-cost averaging to reduce the impact of market volatility on your investments.
  • Rebalance your portfolio periodically to maintain your desired risk-return profile.
  • Monitor the company's financial performance and industry news to make informed decisions.

Why It Matters

Investing in JNJ stock provides exposure to a well-established and diversified healthcare company with strong growth potential. The company's long history of innovation and brand recognition make it a reliable choice for investors seeking long-term returns.

Benefits

  • Potential for capital appreciation: JNJ stock has historically outperformed the broader market, offering investors potential upside.
  • Income generation: JNJ pays a reliable dividend, providing investors with a source of passive income.
  • Diversification: JNJ's healthcare focus provides diversification in an investor's portfolio, reducing overall risk.
Time:2025-01-06 11:44:14 UTC

zxstock   

TOP 10
Related Posts
Don't miss